Request To Download Free Sample of This Strategic Report @- The Global Xerostomia Therapeutics Market is poised for significant growth, with an anticipated reach of over USD 822.14 million by 2026, ...
Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc.
Background: Ocular dryness is a hallmark feature of patients with primary Sjogren’s Disease (pSD). There is still great unmet medical need as treatment options ... for management of dry eye associated ...
Adults with moderately-to-severely active Sjögren’s disease who received investigational FcRn blocker nipocalimab had improvements in disease activity scores at 24 weeks with accompanying significant ...
Adults with moderately-to-severely active Sjögren's disease who received investigational FcRn blocker, nipocalimab, had improvements in disease activity scores at 24 weeks with accompanying ...
Today, there is no single medical treatment approved for metabolic syndrome. Instead, there is a wide range of treatment options for each individual component of the condition. By addressing each ...
Common examples of autoimmune disease include type 1 diabetes, rheumatoid arthritis, multiple sclerosis and psoriasis. Primary antiphospholipid syndrome (PAPS) is a clotting disorder attributed to ...
Management typically involves medications that modify the immune system, but natural treatments may also help reduce symptoms. Lupus is an autoimmune condition. It develops when the immune system ...
What is Known About the Estrogen Deficiency of Menopause & Specific Autoimmune Diseases It is ... use of hormonal replacement treatment and disease. The estrogen withdrawal of menopause, however ...